IGF2 and sarcoma: The study by Rogler and colleagues demonstrated that transgenic mice overexpressing IGF2 develop a broad spectrum of tumors, including lymphomas, hepatocellular carcinoma, sarcoma, squamous cell carcinoma, and thyroid carcinoma.